Document:

Exhibit 4.3

DESCRIPTION OF SHARE CAPITAL

 

The following descriptions of our share capital
and provisions of our amended and restated articles of association are summaries and do not purport to be complete. For a complete description
you should refer to our amended and restated articles of incorporation which are included as an exhibit to our Annual Report on Form 10-K,
and to the applicable provisions of the Israeli law.

 

General

Our authorized share capital consists of 150,000,000
ordinary shares, par value NIS 0.01 per share. All of our outstanding ordinary shares are validly issued, fully paid and non-assessable.
Our ordinary shares are not redeemable and do not have any preemptive rights. We have no preferred shares authorized or outstanding.

 

Registration Number and Purpose of the Company 

 

We are registered with the Israeli Registrar of
Companies. Our registration number is 51-260120-4. Our purpose, as set forth in our amended and restated articles of association, is to
engage in any lawful act or activity

 

Voting Rights

 

All ordinary shares have identical voting and
other rights in all respects.

 

Transfer of Shares

 

Our fully paid ordinary shares are issued in registered
form and may be freely transferred under our amended and restated articles of association, unless the transfer is restricted or prohibited
by another instrument, applicable law or the rules of a stock exchange on which the shares are listed for trade. The ownership or voting
of our ordinary shares by non-residents of Israel is not restricted in any way by our amended and restated articles of association or
the laws of the State of Israel, except for ownership by nationals of some countries that are, or have been, in a state of war with Israel.

Election of Directors

 

Under our amended and restated articles of association,
our board of directors must consist of not less than 5 but no more than 11 directors. Pursuant to our amended and restated articles of
association, each of our directors will appointed by a simple majority vote of holders of our voting shares, participating and voting
at an annual general meeting of our shareholders. In addition, our directors are divided into three classes, one class being elected each
year at the annual general meeting of our shareholders, and serve on our board of directors until they are removed by a vote of 60% of
the total voting power of our shareholders at a general meeting of our shareholders or upon the occurrence of certain events, in accordance
with the Israeli Companies Law, and our amended and restated articles of association. In addition, our amended and restated articles of
association allow our board of directors to fill vacancies on the board of directors or to appoint new directors up to the maximum number
of directors permitted under our amended and restated articles of association. Such directors serve for a term of office equal to the
remaining period of the term of office of the directors(s) whose office(s) have been vacated or in the case of new directors, for a term
of office according to the class to which such director was assigned upon appointment.

 

Dividend and Liquidation Rights 

 

We may declare a dividend to be paid to the holders
of our ordinary shares in proportion to their respective shareholdings. Under the Israeli Companies Law, dividend distributions are determined
by the board of directors and do not require the approval of the shareholders of a company unless the company’s articles of association
provide otherwise. Our amended and restated articles of association do not require shareholder approval of a dividend distribution and
provide that dividend distributions may be determined by our board of directors.

 

     

     

    

 

Pursuant to the Israeli Companies Law, the distribution
amount is limited to the greater of retained earnings or earnings generated over the previous two years, according to our then last reviewed
or audited financial statements, provided that the end of the period to which the financial statements relate is not more than six months
prior to the date of the distribution. If we do not meet such criteria, then we may distribute dividends only with court approval. In
each case, we are only permitted to distribute a dividend if our board of directors and the court, if applicable, determines that there
is no reasonable concern that payment of the dividend will prevent us from satisfying our existing and foreseeable obligations as they
become due.

 

In the event of our liquidation, after satisfaction
of liabilities to creditors, our assets will be distributed to the holders of our ordinary shares in proportion to their shareholdings.
This right, as well as the right to receive dividends, may be affected by the grant of preferential dividend or distribution rights to
the holders of a class of shares with preferential rights that may be authorized in the future.

 

Exchange Controls 

 

There are currently no Israeli currency control
restrictions on remittances of dividends on our ordinary shares, proceeds from the sale of the shares or interest or other payments to
non-residents of Israel, except for shareholders who are subjects of countries that are, or have been, in a state of war with Israel.

 

Shareholder Meetings 

 

Under Israeli law, we are required to hold an
annual general meeting of our shareholders once every calendar year that must be held no later than 15 months after the date of the previous
annual general meeting. All meetings other than the annual general meeting of shareholders are referred to in our amended and restated
articles of association as special general meetings. Our board of directors may call special general meetings whenever it sees fit, at
such time and place, within or outside of Israel, as it may determine. In addition, the Israeli Companies Law provides that our board
of directors is required to convene a special general meeting upon the written request of (i) any two or more of our directors or one-quarter
or more of the members of our board of directors or (ii) one or more shareholders holding, in the aggregate, either (a) 5% or more of
our outstanding issued shares and 1% or more of our outstanding voting power or (b) 5% or more of our outstanding voting power.

 

Subject to the provisions of the Israeli Companies
Law and the regulations promulgated thereunder, shareholders entitled to participate and vote at general meetings are the shareholders
of record on a date to be decided by the board of directors, which may generally be between four and 21 days prior to the date of the
meeting, and in certain circumstances, between four and 40 days prior to the date of the meeting. Furthermore, the Israeli Companies Law
requires that resolutions regarding the following matters must be passed at a general meeting of our shareholders:

 

	 	●	amendments to our articles of association;

 

	 	●	appointment or termination of our auditors;

 

	 	●	appointment of external directors;

 

	 	●	approval of certain related party transactions;

 

	 	●	increases or reductions of our authorized share capital;

 

	 	●	a merger; and

 

	 	●	the exercise of our board of director’s powers by a general meeting, if our board of directors is unable to exercise its powers and the exercise of any of its powers is required for our proper management.

 

The Israeli Companies Law requires that a notice
of any annual general meeting or special general meeting be provided to shareholders at least 21 days prior to the meeting and if the
agenda of the meeting includes the appointment or removal of directors, the approval of transactions with office holders or interested
or related parties, or an approval of a merger, notice must be provided at least 35 days prior to the meeting. Under the Israeli Companies
Law and our amended and restated articles of association, shareholders are not permitted to take action by way of written consent in lieu
of a meeting.

 

    2

     

    

 

Voting Rights

 

Quorum

 

Pursuant to our amended and restated articles of association, holders of our ordinary shares have one vote for each ordinary share held
on all matters submitted to a vote before the shareholders at a general meeting. The quorum required for our general meetings of shareholders
consists of one or more shareholders present in person, by proxy or written ballot who hold or represent between them at least 33 1/3%
of the total outstanding voting rights. A meeting adjourned for lack of a quorum shall be adjourned either to the same day in the next
week, at the same time and place, to such day and at such time and place as indicated in the notice to such meeting, or to such day and
at such time and place as the chairperson of the meeting shall determine. At the reconvened meeting, one or more shareholders present
in person, by proxy or written ballot who hold or represent between them at least 33 1/3% of the total outstanding voting rights shall
constitute a quorum.

 

Vote Requirements 

 

Our amended and restated articles of association
provide that all resolutions of our shareholders require a simple majority vote, unless otherwise required by the Israeli Companies Law
or by our amended and restated articles of association. Under the Israeli Companies Law, each of (i) the approval of an extraordinary
transaction with a controlling shareholder, (ii) the terms of employment or other engagement of the controlling shareholder of the company
or such controlling shareholder’s relative (even if such terms are not extraordinary) requires the approval under “Management–Fiduciary
duties and approval of specified related party transactions under Israeli law” and (iii) approval of certain compensation-related
matters require the approval described in the final prospectus filed with our Form F-1 Registration Statement (No. 333-232302) on June
28, 2019 under “Management–Compensation Committee.” Under our amended and restated articles of association, the alteration
of the rights, privileges, preferences or obligations of any class of our shares requires a simple majority of the class so affected (or
such other percentage of the relevant class that may be set forth in the governing documents relevant to such class), in addition to the
ordinary majority vote of all classes of shares voting together as a single class at a shareholder meeting. Our amended and restated articles
of association also provide that the removal of any director from office or the amendment of the provisions relating to our staggered
board requires the vote of 60% of the total voting power of our shareholders. Another exception to the simple majority vote requirement
is a resolution for the voluntary winding up, or an approval of a scheme of arrangement or reorganization, of the company pursuant to
Section 350 of the Israeli Companies Law, which requires the approval of holders of 75% of the voting rights represented at the meeting
and voting on the resolution.

 

Access to Corporate Records 

 

Under the Companies Law, all shareholders generally
have the right to review minutes of our general meetings, our shareholder register, including with respect to material shareholders, our
articles of association, our financial statements, other documents as provided in the Companies Law, and any document we are required
by law to file publicly with the Israeli Companies Registrar or the Israeli Securities Authority. Any shareholder who specifies the purpose
of its request may request to review any document in our possession that relates to any action or transaction with a related party which
requires shareholder approval under the Companies Law. We may deny a request to review a document if we determine that the request was
not made in good faith, that the document contains a commercial secret or a patent or that the document’s disclosure may otherwise
impair our interests.

 

    3

     

    

 

Acquisitions under Israeli Law 

 

Full Tender Offer 

 

A person wishing to acquire shares of a public
Israeli company and who would as a result hold over 90% of the target company’s issued and outstanding share capital or that of
a certain class of shares is required by the Companies Law to make a tender offer to all of the company’s shareholders or the shareholders
who hold shares of the same class for the purchase of all of the issued and outstanding shares of the company or of the same class, as
applicable.

 

If the shareholders who do not respond to or accept
the offer hold less than 5% of the issued and outstanding share capital of the company or of the applicable class of the shares, all of
the shares that the acquirer offered to purchase will be transferred to the acquirer by operation of law (provided that a majority of
the offerees that do not have a personal interest in such tender offer shall have approved it, which condition shall not apply if offerees
holding less than 2% of the company’s issued and outstanding share capital failed to approve such tender offer).

 

Upon a successful completion of such a full tender
offer, any shareholder that was an offeree in such tender offer, whether the shareholder accepted the tender offer or not, may, within
six months from the date of acceptance of the tender offer, petition the Israeli court to determine whether the tender offer was for less
than fair value and that the fair value should be paid as determined by the court unless the acquirer stipulated that a shareholder that
accepts the offer may not seek appraisal rights. If the shareholders who did not respond or accept the tender offer hold at least 5% of
the issued and outstanding share capital of the company or of the applicable class, or the shareholders who did not accept the tender
offer hold 2% or more of the issued and outstanding share capital of the company (or of the applicable class), the acquirer may not acquire
shares of the company that will increase its holdings to more than 90% of the company’s issued and outstanding share capital or
of the applicable class from shareholders who accepted the tender offer.

 

Special Tender Offer 

 

The Companies Law provides that an acquisition
of shares of a public Israeli company must be made by means of a special tender offer if as a result of the acquisition the purchaser
would become a holder of at least 25% of the voting rights in the company. This rule does not apply if there is already another holder
of at least 25% of the voting rights in the company. Similarly, the Companies Law provides that an acquisition of shares in a public company
must be made by means of a tender offer if as a result of the acquisition the purchaser would become a holder of more than 45% of the
voting rights in the company, if there is no other shareholder of the company who holds more than 45% of the voting rights in the company.

 

These requirements do not apply if the acquisition
(i) occurs in the context of a private placement, provided that the general meeting approved the acquisition as a private offering whose
purpose is to give the acquirer at least 25% of the voting rights in the company if there is no person who holds at least 25% of the voting
rights in the company, or as a private offering whose purpose is to give the acquirer 45% of the voting rights in the company, if there
is no person who holds 45% of the voting rights in the company, (ii) was from a shareholder holding at least 25% of the voting rights
in the company and resulted in the acquirer becoming a holder of at least 25% of the voting rights in the company, or (iii) was from a
holder of more than 45% of the voting rights in the company and resulted in the acquirer becoming a holder of more than 45% of the voting
rights in the company.

 

The special tender offer may be consummated only
if (i) at least 5% of the voting power attached to the company’s outstanding shares will be acquired by the offeror and (ii) the
special tender offer is accepted by a majority of the votes of those offerees who gave notice of their position in respect of the offer,
excluding the votes of a holder of control in the offeror, a person who has personal interest in acceptance of the special tender offer,
holders of 25% or more of the voting rights in the company or anyone on their behalf, including their relatives and entities controlled
by them.

 

In the event that a special tender offer is made,
a company’s board of directors is required to express its opinion on the advisability of the offer, or shall abstain from expressing
any opinion if it is unable to do so, provided that it gives the reasons for its abstention. In addition, the board of directors must
disclose any personal interest each member of the board of directors has in the offer or stems therefrom. An office holder in a target
company who, in his or her capacity as an office holder, performs an action the purpose of which is to cause the failure of an existing
or foreseeable special tender offer or is to impair the chances of its acceptance, is liable to the potential purchaser and shareholders
for damages resulting from his or her acts, unless such office holder acted in good faith and had reasonable grounds to believe he or
she was acting for the benefit of the company. However, office holders of the target company may negotiate with the potential purchaser
in order to improve the terms of the special tender offer, and may further negotiate with third parties in order to obtain a competing
offer.

 

    4

     

    

 

If a special tender offer was accepted by a majority
of the shareholders who announced their stand on such offer, then shareholders who did not respond to the special tender offer or had
objected to the offer may accept the offer within four days of the last day set for the acceptance of the offer.

 

In the event that a special tender offer is accepted,
then the purchaser or any person or entity controlling it or under common control with the purchaser or such controlling person or entity
shall refrain from making a subsequent tender offer for the purchase of shares of the target company and cannot execute a merger with
the target company for a period of one year from the date of the offer, unless the purchaser or such person or entity undertook to effect
such an offer or merger in the initial special tender offer.

 

Merger 

 

The Companies Law permits merger transactions
if approved by each party’s board of directors and, unless certain requirements described under the Companies Law are met, a majority
of each party’s shareholders and, in the case of the target company, a majority vote of each class of its shares, voted on the proposed
merger at a shareholders meeting. The board of directors of a merging company is required pursuant to the Companies Law to discuss and
determine whether in its opinion there exists a reasonable concern that as a result of a proposed merger, the surviving company will not
be able to satisfy its obligations towards its creditors, such determination taking into account the financial status of the merging companies.
If the board of directors has determined that such a concern exists, it may not approve a proposed merger. Following the approval of the
board of directors of each of the merging companies, the boards of directors must jointly prepare a merger proposal for submission to
the Israeli Registrar of Companies.

 

For purposes of the shareholder vote, unless a
court rules otherwise, the merger will not be deemed approved if a majority of the shares represented at the shareholders meeting that
are held by parties other than the other party to the merger, or by any person who holds 25% or more of the outstanding shares or the
right to appoint 25% or more of the directors of the other party, vote against the merger. In addition, if the non-surviving entity of
the merger has more than one class of shares, the merger must be approved by each class of shareholders. If the transaction would have
been approved but for the separate approval of each class or the exclusion of the votes of certain shareholders as provided above, a court
may still approve the merger upon the request of holders of at least 25% of the voting rights of a company, if the court holds that the
merger is fair and reasonable, taking into account the value of the parties to the merger and the consideration offered to the shareholders.
Pursuant to the Companies Law, if a merger is with a company’s controlling shareholder or if the controlling shareholder has a personal
interest in the merger, then the merger is instead subject to the same special majority approval that governs all extraordinary transactions
with controlling shareholders (as described in our final prospectus filed with our Form F-1 Registration Statement (No. 333-232302) on
June 28, 2019 under “Management–Fiduciary duties and approval of specified related party transactions under Israeli law.”).

 

Under the Companies Law, each merging company
must send a copy of the proposed merger plan to its secured creditors. Unsecured creditors are entitled to receive notice of the merger
pursuant to regulations promulgated under the Companies Law. Upon the request of a creditor of either party to the proposed merger, the
court may delay or prevent the merger if it concludes that there exists a reasonable concern that, as a result of the merger, the surviving
company will be unable to satisfy the obligations the target company. The court may further give instructions to secure the rights of
creditors.

 

In addition, a merger may not be completed unless
at least 50 days have passed from the date that a proposal for approval of the merger was filed with the Israeli Registrar of Companies
and 30 days from the date that shareholder approval of both merging companies was obtained.

 

    5

     

    

 

Anti-Takeover Measures 

 

The Israeli Companies Law allows us to create
and issue shares having rights different from those attached to our ordinary shares, including shares providing certain preferred rights
with respect to voting, distributions or other matters and shares having preemptive rights. We have no preferred shares authorized under
our amended and restated articles of association. In the future, if we do authorize, create and issue a specific class of preferred shares,
such class of shares, depending on the specific rights that may be attached to it, may have the ability to frustrate or prevent a takeover
or otherwise prevent our shareholders from realizing a potential premium over the market value of their ordinary shares. The authorization
and designation of a class of preferred shares will require an amendment to our amended and restated articles of association, which requires
the prior approval of the holders of a majority of the voting power attaching to our issued and outstanding shares at a general meeting.
The convening of the meeting, the shareholders entitled to participate and the majority vote required to be obtained at such a meeting
will be subject to the requirements set forth in the Israeli Companies Law as described above in “–Voting Rights.” In
addition, as disclosed under “–Election of directors”, we have a classified board structure which effectively limits
the ability of any investor or potential investor or group of investors or potential investors to gain control of our board of directors.

 

Borrowing Powers

 

Pursuant to the Israeli Companies Law and our
amended and restated articles of association, our board of directors may exercise all powers and take all actions that are not required
under law or under our amended and restated articles of association to be exercised or taken by our shareholders, including the power
to borrow money for company purposes.

 

Changes in Capital

 

Our amended and restated articles of association
enable us to increase or reduce our share capital. Any such changes are subject to Israeli Companies Law and must be approved by a resolution
duly passed by our shareholders at a general meeting by voting on such change in the capital. In addition, transactions that have the
effect of reducing capital, such as the declaration and payment of dividends in the absence of sufficient retained earnings or profits,
require the approval of both our board of directors and an Israeli court.

 

Transfer Agent and Registrar

 

The transfer agent and registrar for our ordinary
shares is Broadridge Corporate Issuer Solutions, Inc. Its address is 1717 Arch Street, Suite 1300, Philadelphia, Pennsylvania 19103, and
its telephone number is (215) 553-5400.

 

Listing

 

Our ordinary shares are listed on The Nasdaq Global
Market under the symbol “GMDA.”

 

 

6Exhibit 10.1

 

indemnification
agreement

 

THIS INDEMNIFICATION AGREEMENT (the “Agreement”),
dated as of ____________, is entered into by and between Gamida Cell Ltd., an Israeli company whose address is 5 Nahum Heftsadie Street
Givaat Shaul, Jerusalem 91340, Israel (the “Company”), and the undersigned Director or Officer of the Company whose
name appears on the signature page hereto (the “Indemnitee”).

 

	WHEREAS,	 	Indemnitee is an Office
Holder (“Nosse Misra”), as such term is defined in the Companies Law, 5759–1999, as amended (the “Companies
Law” and “Office Holder” respectively),
of the Company;

 

	WHEREAS,	 	both the Company and Indemnitee
recognize the increased risk of litigation and other claims being asserted against Office Holders of companies and that highly competent
persons have become more reluctant to serve corporations as directors and officers or in other capacities unless they are provided with
adequate protection through insurance or adequate indemnification against inordinate risks of claims and actions against them arising
out of their service to, and activities on behalf of, companies;

 

	WHEREAS,	 	the Articles of Association
of the Company authorize the Company to indemnify and advance expenses to its Office Holders and provide for insurance and exculpation
to its Office Holders, in each case, to the fullest extent permitted by applicable law and this Agreement is provided to Indemnitee in
accordance with applicable law, the Articles of the Association of the Company and all requisite corporate approvals;

 

	WHEREAS,	 	the Company has determined
that (i) the increased difficulty in attracting and retaining competent persons is detrimental to the best interests of the Company’s
shareholders and that the Company should act to assure such persons that there will be increased certainty of such protection in the
future, (ii) and it is reasonable, prudent and necessary for the Company contractually to obligate itself to indemnify, and to advance
expenses on behalf of, such persons to the fullest extent permitted by applicable law, so that they will serve or continue to serve the
Company free from undue concern that they will not be so indemnified;

 

	WHEREAS,	 	the Company acknowledges
that Indemnitee is relying on the obligations of the Company set forth in this Agreement in agreeing to serve the Company, which obligations
are therefore irrevocable; and

 

	WHEREAS,	 	in recognition of Indemnitee’s
need for substantial protection against loss arising from the Indemnitee’s liability, including costs and expenses incurred by
the Indemnitee due to his position as an Office Holder, in order to assure Indemnitee’s continued service to the Company in an
effective manner and, in part, in order to provide Indemnitee with specific contractual assurance that the indemnification, insurance
and exculpation afforded by the Articles of Association will be available to Indemnitee, the Company wishes to undertake in this Agreement
for the indemnification of and the advancing of expenses to Indemnitee to the fullest extent permitted by applicable law and as set forth
in this Agreement and provide for insurance and exculpation of Indemnitee as set forth in this Agreement.

 

     

     

    

 

NOW, THEREFORE, the parties hereto agree
as follows:

 

 1. INDEMNIFICATION AND INSURANCE.

 

		1.1.	The Company hereby undertakes to indemnify Indemnitee to
the fullest extent permitted by applicable law and the Company’s Articles of Association, as each may be amended from time to time,
for any liability and expense specified in Sections ‎1.1.1 through ‎1.1.4 below, imposed on Indemnitee due to or in connection
with an act performed by such Indemnitee, either prior to or after the date hereof, in Indemnitee’s capacity as an Office Holder,
including, without limitation, as a director, officer, employee, agent or fiduciary of the Company, any subsidiary thereof or any other
corporation, collaboration, partnership, joint venture, trust or other enterprise, in which Indemnitee serves at any time at the request
of the Company (the “Corporate Capacity”). The term “act performed in Indemnitee’s capacity as an Office
Holder” shall include, without limitation, any act, omission and failure to act and any other circumstances relating to or arising
from Indemnitee’s service in a Corporate Capacity. Notwithstanding the foregoing, in the event that the Office Holder is the beneficiary
of an indemnification undertaking provided by a subsidiary of the Company or any other entity, with respect to his Corporate Capacity
with such subsidiary or entity, then the indemnification obligations of the Company hereunder with respect to such Corporate Capacity
shall only apply to the extent that the indemnification by such subsidiary or other entity does not actually fully cover the indemnifiable
liabilities and expenses relating thereto. The following shall be hereinafter referred to as “Indemnifiable Events”:

 

		1.1.1.	Financial liability imposed on Indemnitee in favor of another
person by any court judgment, including a judgment given as a result of a settlement or an arbitrator’s award which has been confirmed
by a court in respect of an act performed by the Indemnitee. For purposes of Section ‎1 of this Agreement, the term “person”
shall include, without limitation, a natural person, firm, partnership, joint venture, trust, company, corporation, limited liability
entity, unincorporated organization, estate, government, municipality, or any political, governmental, regulatory or similar agency or
body;

 

		1.1.2.	Reasonable Expenses (as defined below) expended by the Indemnitee
as a result of an investigation or proceeding instituted against him or her by an authority authorized to conduct such investigation
or proceeding, or in connection with a financial sanction, provided that (1) no indictment (as defined in the Companies Law) was filed
against such office holder as a result of such investigation or proceeding; and (2) no financial liability in lieu of a criminal proceeding
(as defined in the Companies Law) was imposed upon him or her as a result of such investigation or proceeding or if such financial liability
was imposed, it was imposed with respect to an offence that does not require proof of criminal intent;

 

		1.1.3.	Reasonable Expenses expended by an Indemnitee or which were
imposed on an Indemnitee by a court in proceedings filed against the Indemnitee by the Company or in its name or by any other person
or in a criminal charge in respect of which the Indemnitee was acquitted or in a criminal charge in respect of which the Indemnitee was
convicted for an offence which did not require proof of criminal intent;

 

		1.1.4.	A financial obligation imposed upon Indemnitee and reasonable
Expenses expended Indemnitee as a result of an administrative proceeding instituted against Indemnitee. Without derogating from the generality
of the foregoing, such obligation or Expense will include a payment which Indemnitee is obligated to make to an injured party as set
forth in Section 52(54)(a)(1)(a) of the Israeli Securities Law, 1968 – 5728 (the “Israeli Securities Law”) and
Expenses that Indemnitee incurred in connection with a proceeding under Chapters H’3, H’4 or I’1 of the Securities
Law; and

 

    -2-

     

    

 

		1.1.5.	Any other event, occurrence, matter or circumstances under
any law with respect to which the Company may, or will be able to, indemnify the Indemnitee (including, without limitation, in accordance
with Section 56h(b)(1) of the Israeli Securities Law, if and to the extent applicable, and Section 50P(b)(2) of the Israeli Restrictive
Trade Practices Law, 5758-1988 (the “RTP Law”)).

 

For the purpose of this Agreement,
“Expenses” shall include, without limitation, attorneys’ fees and all other costs, expenses and obligations paid
or incurred by Indemnitee in connection with investigating, defending, being a witness in or participating in (including on appeal), or
preparing to defend, be a witness in or participate in any claim, action, suit, proceeding, alternative dispute resolution mechanism,
hearing, inquiry or investigation relating to any matter for which indemnification hereunder may be provided, and costs and expenses paid
or incurred by Indemnitee in successfully enforcing this Agreement. Expenses shall be considered paid or incurred by Indemnitee at such
time as Indemnitee is required to pay or incur such cost or expenses, including upon receipt of an invoice or payment demand. The Company
shall pay the Expenses in accordance with the provisions of Section‎1.3.

 

		1.2.	Notwithstanding anything herein to the contrary, the Company’s undertaking to indemnify the Indemnitee
in advance under Section ‎1.1.1 shall only be with respect to events described in Exhibit A hereto. The Board of Directors
of the Company (the “Board”) has determined that the categories of events listed in Exhibit A are likely
to occur in light of the operations of the Company. The maximum amount of indemnification payable by the Company under Section ‎1.1.1
of this Agreement with respect to all persons with respect to whom the Company undertook to indemnify under agreements similar to this
Agreement (the “Indemnifiable Persons”), for all events described in Exhibit A shall be as set forth
in Exhibit A hereto (the “Limit Amount”). If the Limit Amount is insufficient to cover all the indemnity
amounts payable with respect to all Indemnifiable Persons, then such amount shall be allocated to such Indemnifiable Persons pro rata
according to the percentage of their culpability, as finally determined by a court in the relevant claim, or, absent such determination
or in the event such persons are parties to different claims, based on an equal pro rata allocation among such Indemnifiable Persons.
The Limit Amount payable by the Company as described in Exhibit A is deemed by the Company to be reasonable in light of
the circumstances. The indemnification provided under Section ‎1.1.1 herein shall not be subject to the limitations imposed by this
Section ‎1.2 and Exhibit A if and to the extent such limits are no longer required by the Companies Law.

 

		1.3.	If so requested by Indemnitee, and subject to the Company’s repayment and reimbursements right set
forth in Sections 3 and 5 below, the Company shall pay amounts to cover Indemnitee’s Expenses with respect to which Indemnitee is
entitled to be indemnified under Section ‎1.1 above, as and when incurred. The payments of such amounts shall be made by the Company
directly to the Indemnitee’s legal and other advisors, as soon as practicable, but in any event no later than fifteen (15) days
after written demand by such Indemnitee therefor to the Company, and any such payment shall be deemed to constitute indemnification hereunder.
All amounts paid as indemnification hereunder shall be grossed-up to cover any tax payment that Indemnitee may be required to make if
the indemnification payments are taxable, subject to the Limit Amount if required by applicable law. As part of the aforementioned undertaking,
the Company will make available to Indemnitee any security or guarantee that Indemnitee may be required to post in accordance with an
interim decision given by a court, governmental or administrative body, or an arbitrator, including for the purpose of substituting liens
imposed on Indemnitee’s assets.

 

    -3-

     

    

 

		1.4.	The Company’s obligation to indemnify Indemnitee and advance Expenses in accordance with this Agreement
shall be for such period as Indemnitee shall be subject to any actual, possible or threatened claim, action, suit, demand or proceeding
or any inquiry or investigation, whether civil, criminal or investigative, arising out of the Indemnitee’s service in the Corporate
Capacity as described in Section ‎1.1 above, whether or not Indemnitee is still serving in such position (the “Indemnification
Period).

 

		1.5.	The Company undertakes that, subject to the mandatory limitations under applicable law, as long as it
may be obligated to provide indemnification and advance Expenses under this Agreement, the Company will purchase and maintain in effect
directors and officers liability insurance, which will include coverage for the benefit of the Indemnitee, providing coverage in amounts
as reasonably determined by the Board; provided that, the Company shall have no obligation to obtain or maintain directors and officers
insurance policy if the Company determines in good faith that such insurance is not reasonably available, the premium costs for such insurance
are disproportionate to the amount of coverage provided, or the coverage provided by such insurance is so limited by exclusions that it
provides an insufficient benefit. The Company hereby undertakes to notify the Indemnitee 30 days prior to the expiration or termination
of the directors and officers’ liability insurance.

 

		1.6.	The Company undertakes to give prompt written notice of the commencement of any claim hereunder to the
insurers in accordance with the procedures set forth in each of the policies. The Company shall thereafter diligently take all actions
reasonably necessary under the circumstances to cause such insurers to pay, on behalf of Indemnitee, all amounts payable as a result of
such action, suit, proceeding, inquiry or investigation in accordance with the terms of such policies. The above shall not derogate from
Company’s authority to freely negotiate or reach any compromise with the insurer which is reasonable at the Company’s sole
discretion provided that the Company shall act in good faith and in a diligent manner.

 

		1.7.	In making a determination with respect to entitlement to indemnification hereunder, the person or persons
or entity making such determination shall presume that Indemnitee is entitled to indemnification under this Agreement if Indemnitee has
requested it, and the Company shall have the burden of proof to overcome that presumption in connection with the making of any determination
contrary to that presumption.

 

		2.	SPECIFIC LIMITATIONS ON INDEMNIFICATION.

 

Notwithstanding anything to the contrary
in this Agreement, the Company shall not indemnify or advance Expenses to Indemnitee with respect to (i) any act, event or circumstance
with respect to which it is prohibited to do so under applicable law, or (ii) a counter claim made by the Company or in its name in connection
with a claim against the Company filed by the Indemnitee.

 

		3.	REPAYMENT OF EXPENSES.

 

		3.1.	In the event that the Company provides or is required to provide indemnification with respect to Expenses
hereunder and at any time thereafter the Company determines, based on advice from its legal counsel, that the Indemnitee was not entitled
to such payments, the amounts so indemnified by the Company will be promptly repaid by Indemnitee, unless the Indemnitee disputes the
Company’s determination, in which case the Indemnitee’s obligation to repay to the Company shall be postponed until such dispute
is resolved by a court of competent jurisdiction in a final and non-appealable order.

 

    -4-

     

    

 

		3.2.	Indemnitee’s obligation to repay the Company for any Expenses or other sums paid hereunder shall
be deemed as a loan given to Indemnitee by the Company subject to the minimum interest rate prescribed by Section 3(9) of the Income Tax
Ordinance [New Version], 1961, or any other legislation replacing it, which is not considered a taxable benefit.

 

		4.	SUBROGATION.

 

In the event of payment under this
Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee, who shall execute
all documents required and shall do everything that may be necessary to secure such rights, including the execution of such documents
necessary to enable the Company effectively to bring suit to enforce such rights.

 

		5.	REIMBURSEMENT.

 

The Company shall
not be liable under this Agreement to make any payment in connection with any Indemnifiable Event to the extent Indemnitee has otherwise
actually received payment under any insurance policy or otherwise (without any obligation of Indemnitee to repay any such amount), of
the amounts otherwise indemnifiable hereunder. Any amounts paid to Indemnitee under such insurance policy or otherwise after the Company
has indemnified Indemnitee for such liability or Expense shall be repaid to the Company as soon as practical upon receipt by Indemnitee.

 

The Company hereby
acknowledges that the Indemnitee has now or may have in the future certain rights to indemnification, advancement of expenses and/or insurance
provided by third parties (the “Third Party Indemnitor”), and the Company hereby agrees (a) that the Company is the
indemnitor of first resort (i.e., its obligations to the Indemnitee are primary and any obligation of any Third Party Indemnitor to advance
expenses or to provide indemnification for the same expenses or liabilities incurred by the Indemnitee are secondary), (b) it shall be
required to advance the full amount of expenses incurred by the Indemnitee and shall be liable for the full amount of all expenses, judgments,
penalties, fines and amounts paid in settlement to the fullest extent legally permitted and as required by the terms of this Agreement
and/or the Articles of Association of the Company (or any other agreement between the Company and the Indemnitee), without regard
to any rights the Indemnitee may have against the Third Party Indemnitors, and (c) that it irrevocably waives, relinquishes and releases
any Third Party Indemnitor from any and all claims against any Third Party Indemnitor for contribution, subrogation or any other recovery
of any kind of respect of the subject matters of this Indemnification Agreement. Without altering or expanding any of the Company’s
indemnification obligations hereunder, the Company further agrees that no advancement or payment by any Third Party Indemnitor on the
Indemnitee ‘s behalf with respect to any claim for which Indemnitee has sought indemnification from the Company shall affect the
foregoing and any Third Party Indemnitor shall have a right of contribution and/or be subrogated to the extent of such advancement or
payment to all of the rights of recovery of the Indemnitee against the Company. The Company and the Indemnitee agree that the Third Party
Indemnitors are express third party beneficiaries of the terms of this Section ‎5.

 

		6.	EFFECTIVENESS.

 

The Company represents and warrants
that this Agreement is valid, binding and enforceable in accordance with its terms and was duly adopted and approved by the Company, and
shall be in full force and effect immediately upon its execution and shall continue to be in full force for the duration of the Indemnification
Period.

 

    -5-

     

    

 

		7.	NOTIFICATION AND DEFENSE OF CLAIM.

 

Indemnitee shall notify the Company
of the commencement of any action, suit or proceeding, and of the receipt of any notice or threat that any such legal proceeding has been
or shall or may be initiated against Indemnitee (including any proceedings by or against the Company and any subsidiary thereof), promptly
upon Indemnitee first becoming so aware; but the omission to so notify the Company will not relieve the Company from any liability which
it may have to Indemnitee under this Agreement unless and to the extent that such failure to provide notice materially impact the Company’s
ability to defend such action. Notice to the Company shall be directed to the Chief Executive Officer or Chief Financial Officer of the
Company at the address shown in the preamble to this Agreement (or such other address as the Company shall designate in writing to Indemnitee).
With respect to any such action, suit or proceeding as to which Indemnitee notifies the Company of the commencement thereof and without
derogating from Sections ‎1.1 and ‎2:

 

		7.1.	The Company will be entitled to participate therein at its
own expense.

 

		7.2.	Except as otherwise provided below, the Company, alone or
jointly with any other indemnifying party similarly notified, will be entitled to assume the defense thereof, with counsel selected by
the Company. Indemnitee shall have the right to employ his or her own counsel in such action, suit or proceeding, but the fees and expenses
of such counsel incurred after notice from the Company of its assumption of the defense thereof shall be at the expense of Indemnitee,
unless: (i) the employment of counsel by Indemnitee has been authorized in writing by the Company; (ii) the Company shall have,
in good faith, reasonably concluded that there may be a conflict of interest under the law and rules of attorney professional conduct
applicable to such claim between the Company and Indemnitee in the conduct of the defense of such action; or (iii) the Company has
not in fact employed counsel to assume the defense of such action, in which cases the reasonable fees and expenses of Indemnitee’s
counsel shall be at the expense of the Company. The Company shall not be entitled to assume the defense of any action, suit or proceeding
brought by or on behalf of the Company or as to which the Company shall have reached the conclusion specified in (ii) above.

 

		7.3.	The Company shall not be liable to indemnify Indemnitee under
this Agreement for any amounts or expenses paid in connection with a settlement of any action, claim or otherwise, effected without the
Company’s prior written consent.

 

		7.4.	The Company shall have the right to conduct the defense as
it sees fit in its sole discretion (provided that the Company shall conduct the defense in good faith and in a diligent manner and that
the Company and its counsel shall keep the indemnitee reasonably notified on a regular basis of all events in the action), including
the right to settle or compromise any claim or to consent to the entry of any judgment against Indemnitee without the consent of the
Indemnitee, provided that, the amount of such settlement, compromise or judgment does not exceed the Limit Amount (if applicable) and
is fully indemnifiable pursuant to this Agreement (subject to Section ‎1.2 of this Agreement) and/or applicable law, and any such
settlement, compromise or judgment does not impose any penalty or limitation on Indemnitee without the Indemnitee’s prior written
consent. The Indemnitee’s consent shall not be required if the settlement includes a complete release of Indemnitee, does not contain
any admission of wrong-doing by Indemnitee, and includes monetary sanctions only as provided above. In the case of criminal proceedings
the Company and/or its legal counsel will not have the right to plead guilty or agree to a plea-bargain in the Indemnitee’s name
without the Indemnitee’s prior written consent. Neither the Company nor Indemnitee will unreasonably withhold or delay their consent
to any proposed settlement.

 

    -6-

     

    

 

		7.5.	Indemnitee shall fully cooperate with the Company and shall
give the Company all information and access to documents, files and to his advisors and representatives as shall be within Indemnitee’s
power, in every reasonable way as may be required by the Company with respect to any claim which is the subject matter of this Agreement
and in the defense of other claims asserted against the Company (other than claims asserted by Indemnitee), provided that the Company
shall cover all expenses, costs and fees incidental thereto such that the Indemnitee will not be required to pay or bear such expenses,
costs and fees.

 

		8.	EXCULPATION.

 

Subject to the provisions of the Companies
Law, the Company hereby releases, in advance, the Office Holder from liability to the Company for any damage that arises from the breach
of the Office Holder’s duty of care to the Company (within the meaning of such terms under Sections 252 and 253 of the Companies
Law), other than breach of the duty of care towards the Company in a distribution (as such term is defined in the Companies Law).

 

		9.	NON-EXCLUSIVITY.

 

The rights of the Indemnitee hereunder
shall not be deemed exclusive of any other rights Indemnitee may have under the Company’s Articles of Association, applicable law
or otherwise, and to the extent that during the Indemnification Period the indemnification rights of the then serving Indemnitees are
more favorable to such Indemnitees than the indemnification rights provided under this Agreement, Indemnitee shall be entitled to the
full benefits of such more favorable indemnification rights to the extent permitted by law.

 

		10.	PARTIAL INDEMNIFICATION.

 

If Indemnitee is entitled under any
provision of this Agreement to indemnification by the Company for some or a portion of the Expenses, judgments, fines or penalties actually
or reasonably incurred by Indemnitee in connection with any proceedings, but not, however, for the total amount thereof, the Company shall
nevertheless indemnify Indemnitee for the portion of such Expenses, judgments, fines or penalties to which Indemnitee is entitled under
any provision of this Agreement. Subject to the provisions of Section 4 above, any amount received by Indemnitee (under any insurance
policy or otherwise) shall not reduce the Limit Amount hereunder and shall not derogate from the Company’s obligation to indemnify
the Indemnitee in accordance with the provisions of this Agreement up to the Limit Amount, as set forth in Section ‎1.2.

 

		11.	BINDING EFFECT.

 

This Agreement shall be binding upon
and inure to the benefit of and be enforceable by the parties hereto and their respective successors and permitted assigns. In the event
of a merger or consolidation of the Company or a transfer or disposition of all or substantially all of the business or assets of the
Company, the Indemnitee shall be entitled to the same indemnification and insurance provisions as the most favorable indemnification and
insurance provisions afforded to the then-serving Office Holders of the Company. In the event that in connection with such transaction
the Company purchases a directors and officers’ “tail” or “run-off” policy for the benefit of its then serving
Office Holders, then such policy shall cover Indemnitee and such coverage shall be deemed to be in satisfaction of the insurance requirements
under this Agreement. This Agreement shall continue in effect during the Indemnification Period regardless of whether Indemnitee continues
to serve in a Corporate Capacity.

 

    -7-

     

    

 

Any amendment to the Companies Law,
the Israeli Securities Law, the RTP Law or other applicable law adversely affecting the right of the Indemnitee to be indemnified, insured
or released pursuant hereto shall be prospective in effect, and shall not affect the Company’s obligation or ability to indemnify
or insure the Indemnitee for any act or omission occurring prior to such amendment, unless otherwise provided by applicable law.

 

		12.	SEVERABILITY.

 

The provisions of this Agreement shall
be deemed severable and the invalidity or unenforceability of any provision shall not affect the validity or enforceability of the other
provisions hereof. If any provision of this Agreement, or the application thereof or any circumstance, is invalid or unenforceable, (a)
a suitable and equitable provision shall be substituted therefor in order to carry out, so far as may be valid and enforceable, the intent
and purpose of such invalid or unenforceable provision and (b) the remainder of this Agreement and the application of such provision or
circumstances shall not be affected by such invalidity or unenforceability, nor shall such invalidity or unenforceability affect the validity
or enforceability of such provision, or the application thereof, in any other jurisdiction.

 

		13.	NOTICE.

 

All notices and other communications
pursuant to this Agreement shall be in writing and shall be deemed provided if delivered personally, telecopied, sent by electronic facsimile,
email, reputable overnight courier or mailed by registered or certified mail (return receipt requested), postage prepaid, to the parties
at the addresses shown in the preamble to this Agreement, or to such other address as the party to whom notice is to be given may have
furnished to the other party hereto in writing in accordance herewith. Any such notice or communication shall be deemed to have been delivered
and received (i) in the case of personal delivery, on the date of such delivery, (ii) in the case of telecopier or an electronic facsimile
or email, one business day after the date of transmission if confirmation of receipt is received, (iii) in the case of a reputable overnight
courier, three business days after deposit with such reputable overnight courier service, and (iv) in the case of mailing, on the seventh
business day following that on which the mail containing such communication is posted.

 

		14.	GOVERNING LAW; JURISDICTION.

 

This Agreement shall be governed by
and construed and enforced in accordance with the laws of the State of Israel, without giving effect to the conflicts of law provisions
of those laws. The Company and Indemnitee each hereby irrevocably consent to the exclusive jurisdiction and venue of the courts of Tel
Aviv, Israel for all purposes in connection with any action or proceeding which arises out of or relates to this Agreement.

 

		15.	ENTIRE AGREEMENT AND TERMINATION.

 

This Agreement represents the entire
agreement between the parties and supersedes any other agreements, contracts or understandings between the parties, whether written or
oral, with respect to the subject matter of this Agreement. For the avoidance of doubt, it is hereby clarified that nothing contained
herein derogates from the Company’s right in its sole discretion, subject to applicable law and the Articles of Association of the
Company, to indemnify Indemnitee post factum for any amounts which Indemnitee may be obligated to pay.

 

    -8-

     

    

 

		16.	NO MODIFICATION AND NO WAIVER.

 

No supplement, modification or amendment,
termination or cancellation of this Agreement shall be binding unless executed in writing by both of the parties hereto. No waiver of
any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions hereof (whether or not similar)
nor shall such waiver constitute a continuing waiver. Any waiver shall be in writing. The Company hereby undertakes not to amend its Articles
of Association in a manner which will adversely affect the provisions of this Agreement.

 

		17.	ASSIGNMENTS; NO THIRD PARTY RIGHTS

 

Neither party hereto may assign any
of its rights or obligations hereunder except with the express prior written consent of the other party. Nothing herein shall be deemed
to create or imply an obligation for the benefit of a third party. Without limitation of the foregoing, nothing herein shall be deemed
to create any right of any insurer that provides directors and officers’ liability insurance, to claim, on behalf of Indemnitee,
any rights hereunder.

 

		18.	INTERPRETATION; DEFINITIONS.

 

The obligations
of the Company as provided hereunder shall be interpreted broadly and in a manner that shall facilitate its execution, to the extent permitted
by law, and for the purposes for which it was intended.

 

Unless the context
shall otherwise require: words in the singular shall also include the plural, and vice versa; any pronoun shall include the corresponding
masculine, feminine and neuter forms; the words “include”, “includes” and “including” shall be deemed
to be followed by the phrase “without limitation”; the words “herein”, “hereof” and “hereunder”
and words of similar import refer to this Agreement in its entirety and not to any part hereof; all references herein to Sections or clauses
shall be deemed references to Sections or clauses of this Agreement; any references to any agreement or other instrument or law, statute
or regulation are to it as amended, supplemented or restated, from time to time (and, in the case of any law, to any successor provisions
or re-enactment or modification thereof being in force at the time); any reference to “law” shall include any supranational,
national, federal, state, local, or foreign statute or law and all rules and regulations promulgated thereunder; any reference to a “day”
or a number of “days” (without any explicit reference otherwise, such as to business days) shall be interpreted as a reference
to a calendar day or number of calendar days; reference to month or year means according to the Gregorian calendar; reference to a “company”,
“corporate body” or “entity” shall include a, partnership, firm, company, corporation, limited liability company,
association, joint venture, trust, unincorporated organization, estate, or a government municipality or any political, governmental, regulatory
or similar agency or body, and reference to a “person” shall mean any of the foregoing or a natural person.

 

		19.	COUNTERPARTS

 

This Agreement may be executed in
any number of counterparts, each of which shall be deemed an original and enforceable against the parties actually executing such counterpart,
and all of which together shall constitute one and the same instrument; it being understood that parties need not sign the same counterpart.
The exchange of an executed Agreement (in counterparts or otherwise) by facsimile or by electronic delivery in pdf format shall be sufficient
to bind the parties to the terms and conditions of this Agreement, as an original.

 

[SIGNATURE PAGE TO FOLLOW]

 

    -9-

     

    

 

IN WITNESS WHEREOF,
the parties, each acting under due and proper authority, have executed this Indemnification Agreement as of the date first mentioned above,
in one or more counterparts.

 

	Gamida Cell  Ltd.	 
	 	 	 
	By:	                   	 
	Name:	 	 
	Title:	 	 
	 	 	 
	Indemnitee:	 
	 	 	 
	Name:	           	 
	Title:	 	 
	Signature:  	 	 
	Address:	 	 

 

    -10-

     

    

 

EXHIBIT
A*

 

	 	 	CATEGORY OF INDEMNIFIABLE EVENT	 	LIMIT AMOUNT PER EACH SPECIFIC EVENT WITHIN THIS CATEGORY OF EVENTS  
	 	 	 	 	 
	1.	 	Claims in connection with employment relationships with and/or by employees or consultants of the Company, and in connection with business relations between the Company and its employees, independent contractors, customers, suppliers and various service providers.	 	The greater of (a) twenty-five percent (25%) of the Company’s total shareholders’ equity on a consolidated basis according to the Company’s most recent financial statements as of the time of the actual payment of indemnification; (b) US$150 million; and (c) forty percent (40%) of the Company Total Market Cap (which shall mean the average closing price of the Company’s ordinary shares over the 30 trading days prior to the actual payment of indemnification multiplied by the total number of issued and outstanding shares of the Company as of the date of actual payment) (the “Maximum Amount”).
	 	 	 	 	 
	2. 	 	Negotiations, execution, delivery and performance of agreements of any kind or nature, anti-competitive acts, acts of commercial wrongdoing, approval of corporate actions including the approval of the acts of the Company’s management, their guidance and their supervision, actions concerning the approval of transactions with Office Holders or shareholders, including controlling persons and claims of failure to exercise business judgment and a reasonable level of proficiency, expertise and care with respect to the Company’s business.  	 	The Maximum Amount
	 	 	 	 	 
	3. 	 	Violation, infringement, misappropriation, dilution and other misuse of copyrights, patents, designs, trade secrets and any other intellectual property rights, acts in connection with the registration, assertion or protection of rights to intellectual property and the defense of claims related to intellectual property, breach of confidentiality obligations, acts in regard of invasion of privacy including with respect to databases or personal information, acts in connection with slander and defamation, and claims in connection with publishing or providing any information, including any filings with any governmental authorities, whether or not required under any applicable laws.	 	The Maximum Amount
	 	 	 	 	 
	4. 	 	Violations of securities laws of any jurisdiction, including without limitation, claims under the U.S. Securities Act of 1933, as amended from time to time, or the U.S. Exchange Act of 1934, as amended from time to time, or under the Israeli Securities Law, as amended from time to time, fraudulent disclosure claims, failure to comply with any securities authority or any stock exchange disclosure or other rules and any other claims relating to relationships with investors, debt holders, shareholders and the investment community and any claims related to the Sarbanes-Oxley Act of 2002, as amended from time to time; claims relating to or arising out of financing arrangements, any breach of financial covenants or other obligations towards lenders or debt holders of the Company, class actions, violations of laws requiring the Company to obtain regulatory and governmental licenses, permits and authorizations in any jurisdiction; actions taken in connection with the issuance, purchase, holding or disposition of any type of securities of Company, including, without limitation, the grant of options to purchase any of the same or any offering of the Company’s securities to private investors or to the public, and listing of such securities, or the offer by the Company to purchase securities from the public or from private investors or other holders, and any undertakings, representations, warranties and other obligations related to any such offering, listing or offer or to the Company’s status as a public company or as an issuer of securities.	 	The Maximum Amount

 

    -11-

     

    

 

	5. 	 	Liabilities arising in connection with the conduct of clinical trials, testing, development or manufacturing of any products or services developed, distributed, rendered, sold, provided, licensed or marketed by the Company, and any actions in connection with the distribution, provision, sale, marketing, license or use of such products or services, including without limitation in connection with professional liability and product liability claims.	 	The Maximum Amount
	 	 	 	 	 
	6. 	 	The offering of securities by the Company to the public, including the offering of securities by a shareholder in connection with a secondary offering.	 	The gross proceeds raised by the Company and/or any selling shareholder in such public offering
	 	 	 	 	 
	7. 	 	The offering of securities by the Company to private investors or the offer by the Company to purchase securities from the public and/or from private investors or other holders pursuant to a prospectus, agreements, notices, reports, tenders and/or other proceedings.	 	The Maximum Amount
	 	 	 	 	 
	8. 	 	Events in connection with change in ownership or in the structure of the Company, its reorganization, dissolution, or any decision concerning any of the foregoing, including but not limited to, merger, sale or acquisition of assets, division, change in capital.     	 	The Maximum Amount
	 	 	 	 	 
	9. 	 	Any claim or demand made in connection with any transaction not in the ordinary course of business of the Company, including the sale, lease or purchase of any assets or business.	 	The Maximum Amount
	 	 	 	 	 
	10. 	 	Any claim or demand made by any third party suffering any personal injury and/or bodily injury or damage to business or personal property or any other type of damage through any act or omission attributed to the Company, or its employees, agents or other persons acting or allegedly acting on its behalf, including, without limitation, failure to make proper safety arrangements for the Company or its employees and liabilities arising from any accidental or continuous damage or harm to the Company’s employees, its contractors, its guests and visitors as a result of an accidental or continuous event, or employment conditions, permanent or temporary, in the Company’s offices.	 	The Maximum Amount
	 	 	 	 	 
	11. 	 	Any claim or demand made directly or indirectly in connection with complete or partial failure, by the Company or its directors, officers and employees, to pay, report, keep applicable records or otherwise, of any foreign, federal, state, county, local, municipal or city taxes or other compulsory payments of any nature whatsoever, including, without limitation, income, sales, use, transfer, excise, value added, registration, severance, stamp, occupation, customs, duties, real property, personal property, capital stock, social security, unemployment, disability, payroll or employee withholding or other withholding, including any interest, penalty or addition thereto, whether disputed or not.	 	The Maximum Amount

 

    -12-

     

    

 

	12. 	 	Any administrative, regulatory, judicial or civil actions orders, decrees, suits, demands, demand letters, directives, claims, liens, investigations, proceedings or notices of noncompliance or violation by any governmental entity or other person alleging potential responsibility or liability (including potential responsibility or liability for costs of enforcement investigation, cleanup, governmental response, removal or remediation, for natural resources damages, property damage, personal injuries or penalties or for contribution,  indemnification, cost recovery, compensation or injunctive relief) arising out of, based on or related to (a) the presence of, release, spill, emission, leaning, dumping, pouring, deposit, disposal, discharge, leaching or migration into the environment (each a “Release”) or threatened Release of, or exposure to, any hazardous, toxic, explosive or radioactive substances, wastes or other pollutants, including petroleum or petroleum distillates, asbestos or asbestos-containing material, polychlorinated biphenyls (“PCBs”) or PCB-containing materials or equipment, radon gas, infectious or medical wastes and all other substances or wastes of any nature regulated pursuant to any environmental law, at any location, whether or not owned, operated, leased or managed by the Company or any of its subsidiaries, or (b) circumstances forming the basis of any violation of any environmental law or environmental permit, license, registration or other authorization required under applicable environmental law or public health law.	 	The Maximum Amount
	 	 	 	 	 
	13. 	 	Any administrative, regulatory or judicial actions, orders, decrees, suits, demands, demand letters, directives, claims, liens, investigations, proceedings or notices of noncompliance or violation by any governmental entity or other person alleging the failure to comply with any statute, law, ordinance, rule, regulation, order or decree of any governmental entity applicable to the Company or any of its businesses, assets or operations, or the terms and conditions of any operating certificate or licensing agreement.	 	The Maximum Amount
	 	 	 	 	 
	14. 	 	Participation and/or non-participation at the Company’s Board meetings, bona fide expression of opinion and/or voting and/or abstention from voting at the Company’s Board meetings.	 	The Maximum Amount
	 	 	 	 	 
	15. 	 	Review and approval of the Company’s financial statements, including any action, consent or approval related to or arising from the foregoing, including, without limitations, execution of certificates for the benefit of third parties related to the financial statements.  	 	The Maximum Amount
	 	 	 	 	 
	16. 	 	Violation of laws, rules or regulations requiring the Company to obtain regulatory and governmental licenses, permits and authorizations (including without limitation relating to export, import, encryption, antitrust or competition authorities) or laws related to any governmental grants in any jurisdiction. 	 	The Maximum Amount
	 	 	 	 	 
	17. 	 	Resolutions and/or actions relating to investments in the Company and/or its subsidiaries and/or affiliated companies and/or the purchase and sale of assets, including the purchase or sale of companies and/or businesses, and/or investment in corporate or other entities and/or investments in traded securities and/or any other form of investment.   	 	The Maximum Amount
	 	 	 	 	 
	18. 	 	Liabilities arising out of advertising, including misrepresentations regarding the Company’s products or services and unlawful distribution of emails.	 	The Maximum Amount

 

    -13-

     

    

 

	19. 	 	An announcement or statement, including a position taken or an opinion or representation made in good faith by the Office Holder in the course of his duties or in conjunction with his duties, whether in public or in private, including during a meeting of the Board of Directors of the Company or any of the committees thereof.	 	The Maximum Amount
	 	 	 	 	 
	20. 	 	Management of the Company’s bank accounts, including money management, foreign currency deposits, securities, loans and credit facilities, credit cards, bank guarantees, letters of credit, consultation agreements concerning investments including with portfolio managers, hedging transactions, options, futures, and the like.	 	The Maximum Amount
	 	 	 	 	 
	21. 	 	Any action or decision in relation to protection of work safety and/or working conditions, including with respect to provisions of the law, procedures or standards as applicable in or outside of Israel with relating to protection of work safety, pertaining, inter alia, to contamination, health protection, production processes, distribution, use, treatment, storage and transportation of certain materials, including in connection with corporal damage, property and environmental damages.	 	The Maximum Amount
	 	 	 	 	 
	22. 	 	Any liability arising under any administrative, regulatory, judicial or civil actions orders, decrees, suits, demands, demand letters, directives, claims, liens, investigations, proceedings or notices of noncompliance or violation of Section 50P(b)(2) of the Israeli Restrictive Trade Practices Law, 5758-1988.	 	The Maximum Amount
	 	 	 	 	 
	23. 	 	All actions, consents and approvals relating to a distribution of dividends, in cash or otherwise.	 	The Maximum Amount
	 	 	 	 	 
	 	 	Aggregate Limit Amount for all events together.	 	The Maximum Amount

 

		*	Any reference in this Exhibit A to the Company
shall include the Company and any entity in which the Indemnitee serves in a Corporate Capacity.

 

 

-14-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}]]